Fulgent Genetics, Inc. Chief Scientific Officer Gao Hanlin filed a Form 4 on October 28, 2026, disclosing that 1,645 shares of common stock were withheld on October 26, 2026 to satisfy tax obligations arising from the vesting of restricted stock units.

Key Highlights

  • Reporting person: Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, Inc. (NASDAQ:FLGT)
  • Transaction: 1,645 shares of common stock disposed of (transaction code F) on October 26, 2026
  • Price per share: $20.22, used for the tax withholding calculation
  • Beneficial ownership following transaction: 984,472 shares of common stock, held directly
  • Purpose: Shares withheld to satisfy tax obligations upon vesting of restricted stock units assumed under a merger agreement dated November 7, 2022
  • No derivative securities were reported in Table II of the filing

Fulgent Genetics CSO Gao Hanlin: Tax Withholding Detail on RSU Vesting

According to the filing, Gao Hanlin, identified as Chief Scientific Officer of Fulgent Genetics, Inc., reported the disposition of 1,645 shares of common stock on October 26, 2026. The transaction was coded "F," which the form associates with shares withheld by the issuer to cover tax withholding obligations. The per-share price recorded for the withheld shares was $20.22.

The filing's explanation of responses states that the shares "were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein." The filing further notes those awards were originally reported on a Form 4 filed with the SEC on November 9, 2022.

Following the reported transaction, Gao Hanlin directly holds 984,472 shares of Fulgent Genetics common stock, according to the filing. The Form 4 was signed by Paul Kim as Attorney-in-Fact on October 28, 2026. No derivative securities were reported as acquired, disposed of, or beneficially owned.

What Was Disclosed

Gao Hanlin's Form 4 disclosed a single tax-withholding transaction of 1,645 common shares at $20.22 per share on October 26, 2026, tied to RSU vesting under a 2022 merger agreement, leaving direct ownership of 984,472 shares.